This platform is currently totally free and created by doctors. 🩺

RxIndia

Loading clinical data...

The most trusted clinical drug reference for Indian healthcare professionals. Providing evidence-based monographs, dosage protocols, and expert guidelines to empower better clinical decisions.

Resources

Full Drug Index
Clinical Guidelines
Classifications
Specialties

Weekly Updates

Stay updated with the latest FDA approvals, drug alerts, and clinical practices.

Verified Clinical Information

"This platform is a clinical reference tool for educational purposes only. It is not a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of a qualified physician."

A Medical Intelligence Initiative

About Contact Privacy Terms

Developeredonesolutions

HomeDrug Index

The Drug Registry

Found 3 drugs.

Benralizumab

Anti-IL-5 Receptor alpha (anti-IL-5Rα) monoclonal antibody

Benralizumab causes nearcomplete eosinophil depletion via antibodydependent cellmediated cytotoxicity (ADCC), unlike mepolizumab which neutralizes cir...

View Details

Dupilumab

IL-4 Receptor Alpha Antagonist (Th2 Cytokine Inhibitor)

Set realistic expectations: Clinical improvement in atopic dermatitis may take 4–16 weeks; premature discontinuation is common if patients are not cou...

View Details

Omalizumab

Anti-IgE Monoclonal Antibody

Pretreatment IgE determines dose for asthma; do not remeasure IgE during therapy as levels are artificially elevated by omalizumabIgE complexes CSU ...

View Details

All 3 drugs shown